Entrada Therapeutics (TRDA) Stock Chart & Stock Price History → Everybody laughed when he recommended Netflix (From Stansberry Research) (Ad) Free TRDA Stock Alerts $15.18 -0.14 (-0.91%) (As of 09:48 AM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Entrada Therapeutics Stock Price Performance5 Day Performance+1.54%1 Month Performance+24.94%3 Month Performance+14.14%6 Month Performance-8.94%Year-To-Date Performance+0.60%1 Year Performance+22.32% Receive TRDA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Entrada Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Stansberry ResearchEverybody laughed when he recommended Netflix"This Could be Worth Even More than A.I." Whitney Tilson's nailed many of the most famous stocks of the last 25 years – including Netflix, Amazon, and Apple. Now he's pounding the table on a new technology rolling out across America, which early estimates say could create more wealth than A.I., the personal computer, and the smartphone combined. Click here to see how it could become the No. 1 investment of the next decade. TRDA Stock Chart for Tuesday, May, 21, 2024 TRDA Chart by TradingView Entrada Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/20/2024$14.99$15.32+2.20%$15.41$14.87100,905 shs$517.20 million05/17/2024$14.95$14.99+0.27%$15.34$14.78104,887 shs$506.05 million05/16/2024$14.49$14.95+3.17%$15.01$14.5387,037 shs$504.71 million05/15/2024$14.19$14.49+2.11%$14.81$14.4043,983 shs$489.18 million05/14/2024$14.05$14.19+1.00%$14.83$14.0287,798 shs$479.05 million05/13/2024$14.34$14.05-2.02%$14.84$13.98125,638 shs$474.33 million Get the Latest News and Ratings for TRDA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Entrada Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/10/2024$14.36$14.34-0.14%$14.46$14.0238,904 shs$482.97 million05/09/2024$14.05$14.36+2.21%$14.44$13.8260,495 shs$483.65 million05/08/2024$13.88$14.05+1.22%$14.25$13.5257,449 shs$473.20 million05/07/2024$13.50$13.88+2.81%$14.11$13.3644,564 shs$467.48 million05/06/2024$13.16$13.50+2.58%$13.83$13.2625,801 shs$454.68 million05/03/2024$13.56$13.16-2.95%$13.84$12.9238,162 shs$443.23 million05/02/2024$13.25$13.56+2.34%$13.59$12.7267,224 shs$456.70 million05/01/2024$11.85$13.25+11.81%$13.35$11.9899,275 shs$445.20 million04/30/2024$12.34$11.85-3.97%$12.39$11.8268,824 shs$398.16 million04/29/2024$12.45$12.34-0.88%$12.55$12.1152,697 shs$414.62 million04/26/2024$12.36$12.45+0.73%$12.73$12.3925,818 shs$418.32 million04/25/2024$12.43$12.36-0.56%$12.58$11.9184,124 shs$415.30 million04/24/2024$12.89$12.43-3.57%$12.79$12.3138,559 shs$417.65 million04/23/2024$13.10$12.89-1.60%$14.03$12.8343,975 shs$433.10 million04/22/2024$12.15$13.10+7.82%$13.13$12.20118,886 shs$440.16 million04/19/2024$11.91$12.15+2.02%$12.19$11.8187,455 shs$408.24 million04/18/2024$12.22$11.91-2.54%$12.40$11.83130,286 shs$400.19 million04/17/2024$12.72$12.22-3.93%$12.89$12.1656,429 shs$410.59 million04/16/2024$12.89$12.72-1.32%$13.01$12.5249,596 shs$427.39 million04/15/2024$12.95$12.89-0.46%$13.54$12.69108,935 shs$433.10 million04/12/2024$13.26$12.95-2.34%$13.51$12.7655,707 shs$435.12 million04/11/2024$12.52$13.26+5.91%$13.29$12.1892,010 shs$445.54 million04/10/2024$13.28$12.52-5.72%$13.32$12.23181,822 shs$420.67 million04/09/2024$13.45$13.28-1.26%$13.66$13.0169,240 shs$446.21 million04/08/2024$13.81$13.45-2.61%$14.13$13.3956,868 shs$451.93 million04/05/2024$13.83$13.81-0.14%$14.06$13.53104,020 shs$464.02 million04/04/2024$13.81$13.83+0.14%$14.31$13.6852,003 shs$464.70 million04/03/2024$13.88$13.81-0.50%$14.22$13.6255,551 shs$464.02 million04/02/2024$13.76$13.88+0.87%$13.96$13.1764,911 shs$466.37 million04/01/2024$14.17$13.76-2.89%$14.38$13.4170,847 shs$462.34 million03/29/2024$14.17$14.17$14.51$13.67105,311 shs$476.13 million03/28/2024$14.35$14.17-1.25%$14.51$13.67105,311 shs$476.11 million03/27/2024$13.76$14.35+4.29%$14.50$13.6646,082 shs$482.16 million03/26/2024$13.38$13.76+2.84%$14.00$13.2767,944 shs$462.34 millionEverybody laughed when he recommended Netflix (Ad)"This Could be Worth Even More than A.I." Whitney Tilson's nailed many of the most famous stocks of the last 25 years – including Netflix, Amazon, and Apple. Now he's pounding the table on a new technology rolling out across America, which early estimates say could create more wealth than A.I., the personal computer, and the smartphone combined. Click here to see how it could become the No. 1 investment of the next decade.03/25/2024$13.72$13.38-2.48%$13.99$13.1238,641 shs$449.57 million03/22/2024$13.54$13.72+1.33%$13.96$13.3464,728 shs$460.99 million03/21/2024$13.35$13.54+1.42%$13.80$13.1171,898 shs$454.94 million03/20/2024$12.70$13.35+5.12%$13.53$12.3659,837 shs$448.56 million03/19/2024$12.41$12.70+2.34%$12.97$12.2136,200 shs$426.73 million03/18/2024$12.78$12.41-2.90%$12.78$12.3347,845 shs$416.98 million03/15/2024$12.20$12.78+4.75%$12.81$12.09111,858 shs$426.47 million03/14/2024$12.71$12.20-4.01%$12.88$11.8790,555 shs$407.09 million03/13/2024$11.58$12.71+9.76%$12.82$11.35170,506 shs$424.13 million03/12/2024$11.76$11.58-1.53%$11.97$11.4374,657 shs$386.43 million03/11/2024$12.68$11.76-7.26%$12.70$11.6355,466 shs$392.43 million03/08/2024$12.58$12.68+0.79%$12.89$12.3243,125 shs$423.13 million03/07/2024$12.39$12.58+1.53%$12.88$12.2069,769 shs$419.80 million03/06/2024$12.28$12.39+0.90%$12.76$12.02104,101 shs$413.45 million03/05/2024$12.38$12.28-0.81%$13.32$11.92144,569 shs$409.76 million03/04/2024$13.73$12.38-9.83%$13.82$12.10107,735 shs$413.12 million03/01/2024$13.23$13.73+3.78%$13.73$13.13161,348 shs$458.17 million02/29/2024$12.99$13.23+1.85%$13.68$12.8998,097 shs$441.49 million02/28/2024$13.65$12.99-4.84%$13.95$12.8859,506 shs$433.48 million02/27/2024$13.82$13.65-1.23%$14.45$13.34114,666 shs$455.50 million02/26/2024$13.35$13.82+3.52%$13.96$13.16125,177 shs$461.17 million02/23/2024$13.24$13.35+0.83%$13.62$12.8993,528 shs$445.49 million02/22/2024$13.30$13.24-0.45%$13.57$12.89102,908 shs$441.82 million02/21/2024$13.62$13.30-2.35%$13.60$12.80107,575 shs$443.82 million02/20/2024$14.38$13.62-5.29%$14.55$13.4274,038 shs$454.47 million Related Companies: Adlai Nortye Stock Price Chart Lexicon Pharmaceuticals Stock Price Chart Acelyrin Stock Price Chart Oculis Stock Price Chart Corbus Pharmaceuticals Stock Price Chart Fulcrum Therapeutics Stock Price Chart Theravance Biopharma Stock Price Chart Larimar Therapeutics Stock Price Chart PepGen Stock Price Chart Travere Therapeutics Stock Price Chart Receive TRDA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Entrada Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:TRDA) was last updated on 5/21/2024 by MarketBeat.com Staff From Our PartnersDid You Get Your Free Bitcoin Yet?Crypto Swap Profits4 Cryptos BETTER than BitcoinTrue Market Insiders[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaBill Clinton Backing Biden Replacement???The Freeport SocietyTop 5 Tech Stocks to Buy for 2024Daily Market AlertsThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarWarren Buffett's "mystery stock"Stansberry ResearchThis Could be Your “Big Money” AI MomentInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Entrada Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.